- Previous Close
8.70 - Open
8.40 - Bid 7.75 x 240000
- Ask 8.05 x 230000
- Day's Range
8.40 - 8.40 - 52 Week Range
7.75 - 10.20 - Volume
9 - Avg. Volume
0 - Market Cap (intraday)
4.209B - Beta (5Y Monthly) 0.95
- PE Ratio (TTM)
840.00 - EPS (TTM)
0.01 - Earnings Date May 27, 2025
- Forward Dividend & Yield 0.23 (2.72%)
- Ex-Dividend Date Nov 27, 2024
- 1y Target Est
--
ALS Limited provides professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia/Pacific, Europe, the Middle East, and the Americas. It operates in two segments, Commodities and Life Sciences. The Commodities segment offers assaying and analytical testing, and metallurgical services for the mining and mineral exploration companies. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. This segment also provides coal sampling, analysis and certification, formation evaluation, and related analytical testing services. The Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets; and microbiological, physical, and chemical testing services. This segment provides analytical testing data to assist consulting and engineering firms, industries, and governments. ALS Limited was founded in 1863 and is headquartered in Brisbane, Australia.
www.alsglobal.com19,565
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: CP4.F
View MorePerformance Overview: CP4.F
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CP4.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CP4.F
View MoreValuation Measures
Market Cap
4.21B
Enterprise Value
5.22B
Trailing P/E
1.18k
Forward P/E
20.70
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.64
Price/Book (mrq)
6.27
Enterprise Value/Revenue
3.37
Enterprise Value/EBITDA
23.85
Financial Highlights
Profitability and Income Statement
Profit Margin
0.23%
Return on Assets (ttm)
7.98%
Return on Equity (ttm)
0.68%
Revenue (ttm)
2.7B
Net Income Avi to Common (ttm)
6.2M
Diluted EPS (ttm)
0.01
Balance Sheet and Cash Flow
Total Cash (mrq)
254.6M
Total Debt/Equity (mrq)
175.51%
Levered Free Cash Flow (ttm)
242.18M